CD155 is a putative therapeutic target in medulloblastoma.Published in:Clinical & Translational Oncology, 2023, v. 25, n. 3, p. 696, doi. 10.1007/s12094-022-02975-9By:Li, Sean;McLendon, Roger;Sankey, Eric;Kornahrens, Reb;Lyne, Anne-Marie;Cavalli, Florence Marie Géraldine;McKay, Zachary;Herndon II, James Emmett;Remke, Marc;Picard, Daniel;Gromeier, Matthias;Brown, Michael;Thompson, Eric MichaelPublication type:Article